Recombinant PDCD1 (Spartalizumab Biosimilar) 抗体
This anti-PDCD1 (Spartalizumab Biosimilar) antibody is a Human 单克隆 antibody detecting PDCD1 (Spartalizumab Biosimilar) in FACS, BLI, ELISA, Func 和 SPR. Suitable for 人.
Quick Overview for Recombinant PDCD1 (Spartalizumab Biosimilar) 抗体 (ABIN7581628)
抗原
PDCD1 (Spartalizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This PDCD1 (Spartalizumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
原理
- Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab)
-
产品特性
- Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.56 kDa.
-
纯度
- >95 %
-
亚型
- IgG4 S228P
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- PDCD1 (Spartalizumab Biosimilar)
-
物质类
- Biosimilar
-
分子量
- 145.56 kDa
-
UniProt
- Q15116
抗原
-
You are here:
